Scherrer, Kristen Hymel https://orcid.org/0000-0002-4023-1706
Fuller, Jessica
Shenvi, Christina https://orcid.org/0000-0003-2944-8581
Article History
Received: 4 August 2025
Accepted: 30 November 2025
First Online: 22 December 2025
Declarations
:
: The authors have no disclosures relevant to this work. Other Disclosures: CS has the following other disclosures: Speaker for Astra Zeneca (ended 09/2024), advisory board for Noven Pharmaceuticals (ended 05/2025).
: The authors have no disclosures relevant to this work.
: The study was reviewed by the Institutional Review Board (#22-1797) and deemed exempt.